Citation Impact
Citing Papers
Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody
2010 StandoutNobel
FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
2011
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
A systematic review of the impact of stigma and nihilism on lung cancer outcomes
2012
Immunotherapy of cancer in 2012
2012
Cancer treatment and survivorship statistics, 2022
2022 Standout
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
2010
Dendritic cells as therapeutic vaccines against cancer
2005
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Cytokine Maturation Followed by CD40L mRNA Electroporation Results in a Clinically Relevant Dendritic Cell Product Capable of Inducing a Potent Proinflammatory CTL Response
2008
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Swords into plowshares: IL-23 repurposes tumor immune surveillance
2007
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
DC-based cancer vaccines
2007
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
2007 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function
2005
HIV gag protein is efficiently cross‐presented when targeted with an antibody towards the DEC‐205 receptor in Flt3 ligand‐mobilized murine DC
2009 StandoutNobel
Immunology and immunotherapy approaches for prostate cancer
2007
IL‐15‐induced human DC efficiently prime melanoma‐specific naive CD8+ T cells to differentiate into CTL
2007
The Human T Cell Response to Melanoma Antigens
2006
Cancer immunotherapy via dendritic cells
2012 Standout
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines
2016
Colorectal cancer
2019 Standout
Doctors' communication of trust, care, and respect in breast cancer: qualitative study
2004
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma
2011
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
2004
The ReNAissanCe of mRNA-based cancer therapy
2014
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival
2009
Taking dendritic cells into medicine
2007 StandoutNatureNobel
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
2006
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
EGFR in colorectal cancer: more than a simple receptor
2006
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2008 StandoutNobel
Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity
2006
Helper role of NK cells during the induction of anticancer responses by dendritic cells
2004
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
2008 StandoutNature
Cancer vaccines and carbohydrate epitopes
2011
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Understanding the IL-23–IL-17 immune pathway
2005
IFN‐α enhances CD40 ligand‐mediated activation of immature monocyte‐derived dendritic cells
2002
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
2011
Cancer immunotherapy with mRNA‐transfected dendritic cells
2004
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
2006 StandoutNature
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand
2004
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
2008
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo
2007 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway
2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
2004
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
A Virological View of Innate Immune Recognition
2012
Targeted delivery of methotrexate to epidermal growth factor receptor–positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates
2006
Bone Marrow-Derived Dendritic Cells Generated in the Presence of Resolvin E1 Induce Apoptosis of Activated CD4+ T Cells
2008
Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
2006
An Activatable Prodrug for the Treatment of Metastatic Tumors
2014
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of β cells
2007 StandoutNobel
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
2011
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells
2004
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
2010
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Michael Jefford being referenced
What Should a Support Program for People with Lung Cancer Look Like? Differing Attitudes of Patients and Support Group Facilitators
2010
Phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with metastatic (MET) chemotherapy refractory K-RAS wild-type (WT) colorectal carcinoma (CRC): The NCIC Clinical Trials Group and AGITG CO.20 trial.
2012
Severe hypoglycaemia after long‐acting octreotide in a patient with an unrecognized malignant insulinoma
2007
Informing and involving cancer patients in their own care
2002
Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer
2005
The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews
2021
The use of dendritic cells in cancer therapy
2001
Phase II Trial of Continuous Infusion Carboplatin, 5-Fluorouracil, and Radiotherapy for Localized Cancer of the Esophagus
2002
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli
2003
Nonpharmacologic Strategies for Managing Common Chemotherapy Adverse Effects: A Systematic Review
2008
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets
2002
IL-1β Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation
2002
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.
2004
Rational approaches to human cancer immunotherapy
2003